This inventor holds 4 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Benhealth Biopharmaceutic (Shenzhen) Co., Ltd., Shenzhen Genebiohealth Co. Ltd.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Guangdong, CN (2021)
- Shenzhen, CN (2018 - 2022)
Company Filing History:
3 out of 3 
1 out of 1 Years Active: 2018-2022
Title: Haoyang Yu: Innovator in Tumor Therapy
Introduction
Haoyang Yu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies for cancer treatment. With a total of 4 patents to his name, Yu is recognized for his groundbreaking work in antibody technology.
Latest Patents
One of Haoyang Yu's latest patents is titled "Bispecific antibody and antibody conjugate for tumor therapy and use thereof." This invention features a bispecific antibody that includes an anti-MUC1 VHH antibody fragment and an anti-CD16 VHH antibody fragment. The antibody fragment is derived from a heavy chain camelid antibody, showcasing a high binding affinity to the antigen. This innovative approach allows the antibody molecule to specifically bind to MUC1 and CD16 molecules, enhancing the killing effect of NK cells on MUC1-positive expression cells and inhibiting the growth of MUC1-positive tumors. Another notable patent is "Multi-specific binding conjugate, related pharmaceutical compositions and use." This invention involves a multi-specific binding conjugate that comprises binding moieties for two or more different receptors, co-receptors, antigens, or cellular markers, coupled by a nanomaterial. This conjugate can be utilized to modulate immune responses and treat various diseases, including cancer and autoimmune conditions.
Career Highlights
Haoyang Yu has worked with several notable companies in the biopharmaceutical sector. He has been associated with Benhealth Biopharmaceutic (Shenzhen) Co., Ltd. and Shenzhen Genebiohealth Co., Ltd. His work in these organizations has contributed to advancements in therapeutic solutions and innovative drug development.
Collaborations
Throughout his career, Yu has collaborated with talented individuals in the field. Notable coworkers include Zhengcheng Li and Jing Su, who have contributed to his research and development efforts.
Conclusion
Haoyang Yu is a distinguished inventor whose work in antibody technology and tumor therapy has the potential to revolutionize cancer treatment. His innovative patents and collaborations highlight his commitment to advancing biopharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile